Healthcare Realty Trust Incorporated (NYSE:HR) Stock Has Average Target Price of $21.36 According to Analysts

Key Points

• Analysts have a “Hold” consensus on Healthcare Realty Trust, with seven hold and five buy ratings among 12 analysts; the average price target is $21.36.
• The REIT reported quarterly EPS of -$0.05, missing the $0.41 consensus, while revenue of $286.64 million topped estimates but fell 3.4% year over year.
• Healthcare Realty Trust declared a quarterly dividend of $0.24 per share, equivalent to $0.96 annually and a yield of about 5%.

Healthcare Realty Trust Incorporated (NYSE:HR - Get Free Report) has been assigned an average recommendation of "Hold" from the twelve analysts that are presently covering the stock, MarketBeat Ratings reports. Seven research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1 year target price among brokerages that have updated their coverage on the stock in the last year is $21.36.

HR has been the topic of a number of recent research reports. Jefferies Financial Group began coverage on shares of Healthcare Realty Trust in a research note on Tuesday, September 15th. They set a "hold" rating and a $20.00 price target on the stock. Weiss Ratings restated a "hold (c-)" rating on shares of Healthcare Realty Trust in a research note on Wednesday, October 28th. Royal Bank Of Canada raised their price objective on shares of Healthcare Realty Trust from $21.00 to $22.00 and gave the stock a "sector perform" rating in a report on Friday, August 7th. Wells Fargo & Company reduced their price objective on shares of Healthcare Realty Trust from $20.00 to $18.00 and set an "equal weight" rating for the company in a report on Monday, October 19th. Finally, UBS Group decreased their target price on shares of Healthcare Realty Trust from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Tuesday, October 13th.

Insider Buying and Selling

In other Healthcare Realty Trust news, COO Robert Hull sold 21,000 shares of Healthcare Realty Trust stock in a transaction that occurred on Tuesday, September 8th. The stock was sold at an average price of $19.11, for a total transaction of $401,310.00. Following the sale, the chief operating officer directly owned 276,338 shares of the company's stock, valued at approximately $5,280,819.18. The trade was a 7.06% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.56% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Healthcare Realty Trust

A number of hedge funds have recently modified their holdings of HR. Fifth Third Bancorp raised its position in Healthcare Realty Trust by 1,293.6% in the 1st quarter. Fifth Third Bancorp now owns 295,660 shares of the real estate investment trust's stock valued at $5,023,000 after purchasing an additional 274,445 shares during the last quarter. Edgestream Partners L.P. bought a new stake in shares of Healthcare Realty Trust during the first quarter worth $6,490,000. NEOS Investment Management LLC bought a new stake in shares of Healthcare Realty Trust during the second quarter worth $2,214,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Healthcare Realty Trust during the second quarter worth $3,070,000. Finally, Envestnet Asset Management Inc. grew its holdings in shares of Healthcare Realty Trust by 8.4% during the second quarter. Envestnet Asset Management Inc. now owns 1,190,084 shares of the real estate investment trust's stock worth $24,004,000 after purchasing an additional 92,102 shares during the last quarter.

Healthcare Realty Trust Trading Up 0.3%

Shares of HR stock opened at $19.18 on Wednesday. The stock has a 50 day moving average of $18.16 and a two-hundred day moving average of $18.83. Healthcare Realty Trust has a 12 month low of $16.31 and a 12 month high of $22.04. The company has a market capitalization of $6.58 billion, a P/E ratio of -137.04 and a beta of 0.92.

Healthcare Realty Trust (NYSE:HR - Get Free Report) last released its quarterly earnings data on Thursday, October 29th. The real estate investment trust reported ($0.05) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.41 by ($0.46). The firm had revenue of $286.64 million for the quarter, compared to the consensus estimate of $275.27 million. Healthcare Realty Trust had a negative net margin of 3.96% and a negative return on equity of 1.02%. The business's revenue for the quarter was down 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.41 earnings per share. Sell-side analysts predict that Healthcare Realty Trust will post 1.66 earnings per share for the current fiscal year.

Healthcare Realty Trust Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 20th. Shareholders of record on Tuesday, November 10th will be paid a dividend of $0.24 per share. The ex-dividend date is Tuesday, November 10th. This represents a $0.96 dividend on an annualized basis and a yield of 5.0%. Healthcare Realty Trust's dividend payout ratio (DPR) is currently -685.71%.

Healthcare Realty Trust Company Profile

Healthcare Realty Trust Incorporated NYSE: HR is a real estate investment trust focused on owning, managing, acquiring and developing outpatient healthcare properties. Its portfolio primarily includes medical office buildings, ambulatory surgery centers, outpatient facilities and other properties used by healthcare providers.

The company leases space to health systems, physician groups and other healthcare organizations, with properties generally located on or near hospital campuses and in growing outpatient care settings.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.